logo
13:34 Dec 05

Syngene International Ltd.

Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals
Up
637.45
-4.90 (-0.76%)
Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals

Syngene International Ltd. Financials

Syngene International Ltd.
Sector Pharmaceuticals & Biotechnology
Industry Pharmaceuticals
Up
637.45
-4.90 (-0.76%)
13:34 Dec 05
Quality
image/svg+xml

46/100
Medium Financial Strength

Valuation
image/svg+xml

32/100
Mid Valuation

Technical

36/100
Technically Neutral

Strength

5

Weakness

5

Opportunity

1

Threats

0

10.49 %

ROE %

7.30 %

ROA %

11.62

EPS

117.44

BVPS

13.62 %

Net Profit Margin

Mar 2022 Mar 2023 Mar 2024 Mar 2025 TTM 2025
Net Sales
2604.2 3192.9 3488.6 3642.4 3727.2
Operating Expenses +
1808.1 2258.5 2474.2 2600.6 2648.8
Raw Material
770.6 902.2 873.6 925.4 940.3
Increase Decrease in Cost
-21.6 -42 56.6 17.1 -13.7
Other Manufacturing Expense
0 0 0 0 0
Employee Cost
718.1 841.7 888.7 983.9 1015.7
Miscellaneous Expenses
341 556.6 655.3 674.2 706.5
Operating Profit
796.1 934.4 1014.4 1041.8 1078.4
Other Income
52.8 70.9 90.6 71.8 71.4
Depreciation
309.7 366.5 425.9 432.6 436.9
Interest
24.1 45.2 47.2 53.1 53
Profit before tax and exceptio..
515.1 593.6 631.9 627.9 659.9
Exceptional Items
-30.7 0 -11.1 32 0
PBT
484.4 593.6 620.8 659.9 659.9
Provision for Taxation
88.6 129.2 110.8 163.7 152.7
Net Profit
395.8 464.4 510 496.2 507.2
NET Profit after MI
395.8 464.4 510 496.2 507.2
EPS
9.82 11.51 12.69 12.34 12.63
Operating Profit Margin (%)
30.57 29.26 29.08 28.6 28.93
Net Profit Margin (%)
15.2 14.54 14.62 13.62 13.61

Syngene International Ltd. Shareholding

Promoter

FII

Public

All Data in Percentage (%)

Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025
Promoter 52.70 52.70 52.70 52.70 54.70 54.70
FII 16.30 16.50 19.50 20.60 20.70 20.60
Public 24.60 24.10 21.50 19.60 17.50 16.80
Others 6.40 6.70 6.30 7.10 7.10 7.90
Shareholder Shares Holding %
Research 360 logo
Download Our App On: